One in Five Britons Suffer from Asthma
As cold air and low temperatures set in, independent analyst firm Datamonitor Healthcare has revealed that around one in five Britons will suffer the effects of asthma this winter.
Across the five major EU markets* the UK has the highest prevalence of diagnosed asthmatics with 18% or 11.1 million of the population living with the condition. The numbers and hence the proportion of population living with asthma is lower in other countries in the five major EU markets where prevalence proportions only range from 6% to 11%.
Sabada Dube, lead epidemiologist at Datamonitor Healthcare commented: “Although the actual prevalent proportion of diagnosed asthma will remain constant in the next 10 years, the actual number of people with asthma is set to increase steadily, hitting about 11.4 million by 2021."
Asthma is a condition that affects the airways, which carry air in and out of the lungs. When someone comes into contact with an asthma trigger, such as cold air, the respiratory muscles tighten, making it difficult to breathe.
According to research by Datamonitor Healthcare, rising population numbers together with the launch of new biologic therapies and other pipeline products will see the asthma market continue its trend of solid growth. In the UK, sales for asthma are expected to reach $1.2 billion by 2021.
* The 5 major EU markets are France, Germany, Italy, Spain and the UK
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance